Medibio Share Price and Company Fundamentals



Price
$0.001
Change
-0.001 (-50.000%)
52 week
0.001 - 0.012

Last traded: Yesterday at 11:53 PM

Medibio Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is headquartered in Melbourne, Australia.

Key Metrics

PE ratio

-

PB ratio

0.47

Dividend yield

0.00%

Beta

1.66

Market cap

-

Enterprise value

-

Company profile

Primary activitiesDevelopment of diagnostic heart rate variability technology for mental health diagnosis
Industry / SectorHealth Information Services / Healthcare
Websitehttps://medibio.com.au
Mailing address100 Albert Road Level 4 South Melbourne Melbourne VIC 3205 Australia
Phone / Fax61 3 9692 7222 / 61 3 9077 9233
Share registryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

More: Medibio Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Medibio paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MEB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

MEB's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on Medibio.

NameTitleAgeTotal Pay
Dr. Thomas R. Young M.D.Chief Exec. Officer
Ms. Renee Stanton-HorneOperations & Account Mang.
Ms. Stephanie OttensInvestor Relations Director
Mr. Josh PurdyPR Director
Dr. Michael PlayerHead of Research
Dr. Matthew FlaxHead of Algorithm Devel. Team
Mr. Archie Defillo M.D.Chief Medical Officer
Ms. Jennifer SolitarioSr. VP of Corp. Health
Mr. Massimiliano GrassiHead of Artificial Intelligence
Mr. Mathew Watkins C.A.Company Sec.

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-265.83%

Return on assets

-12.92%

Return on equity

-108.12%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Medibio is and its enterprise value is .

The MEB's stocks Beta value is 1.66 making it 66% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Medibio (MEB)

Medibio (ASX:MEB) Frequently Asked Questions

1. What is Medibio's Stock Symbol?

Medibio trades on ASX under the ticker symbol "MEB".

2. What is Medibio's stock price today?

One share of MEB stock can currently be purchased for approximately $0.001.

3. How can I contact Medibio?

Medibio's mailing address is 100 Albert Road Level 4 South Melbourne Melbourne VIC 3205 Australia. The company can be reached via phone at 61 3 9692 7222.

4. What is Medibio's official website?

The official website of Medibio is https://medibio.com.au.

5. Which share registry manages Medibio's stock?

Medibio's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.